HighTower Advisors LLC trimmed its holdings in CME Group Inc. (NASDAQ:CME – Free Report) by 6.9% in the 3rd quarter, HoldingsChannel reports. The firm owned 279,324 shares of the financial services provider’s stock after selling 20,687 shares during the quarter. HighTower Advisors LLC’s holdings in CME Group were worth $73,177,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. BlackRock Inc. purchased a new stake in CME Group during the 2nd quarter valued at $6,749,965,000. Bank of America Corp DE lifted its position in CME Group by 39.1% during the first quarter. Bank of America Corp DE now owns 4,019,944 shares of the financial services provider’s stock valued at $1,187,290,000 after acquiring an additional 1,130,587 shares during the last quarter. Bank of New York Mellon Corp purchased a new stake in shares of CME Group during the second quarter worth about $867,313,000. Alphabet Inc. purchased a new position in shares of CME Group in the second quarter worth $769,376,000. Finally, Mitsubishi UFJ Asset Management Co. Ltd. purchased a new position in CME Group in the 2nd quarter worth $629,771,000. 87.75% of the stock is owned by institutional investors.
Trending Headlines about CME Group
These are some of the CME headlines that stood out recently:
- Neutral Sentiment: Extensive coverage of the CME Group Tour Championship, the LPGA season finale, keeps CME’s name visible through its golf sponsorship. Reports focus on the field, event format, prize money, and viewing details, with no direct financial impact identified. CME Group Tour Championship coverage
- Neutral Sentiment: CEO Terry Duffy discussed the Tour Championship and prediction markets in an interview. The headline signals interest in prediction markets, but does not indicate a specific new product or financial commitment. CME Group CEO Terry Duffy on the Tour Championship and prediction markets
- Negative Sentiment: A valuation analysis says CME shares look fully valued after a 69% advance, raising the risk that further gains may be harder to achieve and potentially adding pressure to the stock. CME Group stock looks fully valued after its 69% run
CME Group Trading Down 0.4%
Shares of CME Group stock opened at $310.25 on Thursday. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. CME Group Inc. has a 1 year low of $218.31 and a 1 year high of $329.16. The company has a market capitalization of $111.05 billion, a P/E ratio of 25.66, a P/E/G ratio of 3.80 and a beta of 0.15. The business has a 50 day moving average price of $288.15 and a 200 day moving average price of $281.93.
CME Group (NASDAQ:CME – Get Free Report) last posted its quarterly earnings data on Wednesday, October 21st. The financial services provider reported $3.02 EPS for the quarter, beating analysts’ consensus estimates of $2.99 by $0.03. The business had revenue of $1.74 billion for the quarter, compared to analyst estimates of $1.71 billion. CME Group had a return on equity of 16.23% and a net margin of 63.33%. The business’s revenue for the quarter was up 10.6% compared to the same quarter last year. During the same quarter last year, the company earned $2.68 earnings per share. Sell-side analysts anticipate that CME Group Inc. will post 12.35 EPS for the current fiscal year.
CME Group Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Wednesday, December 30th. Shareholders of record on Friday, December 11th will be paid a $1.30 dividend. This represents a $5.20 annualized dividend and a yield of 1.7%. The ex-dividend date of this dividend is Friday, December 11th. CME Group’s payout ratio is presently 42.66%.
Insider Buying and Selling
In other news, insider Julie Winkler sold 10,079 shares of CME Group stock in a transaction on Monday, November 2nd. The stock was sold at an average price of $305.15, for a total value of $3,075,606.85. Following the completion of the sale, the insider owned 21,482 shares of the company’s stock, valued at $6,555,232.30. The trade was a 31.93% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Sunil Cutinho sold 5,000 shares of the stock in a transaction dated Tuesday, October 27th. The stock was sold at an average price of $298.70, for a total value of $1,493,500.00. Following the transaction, the insider owned 20,037 shares in the company, valued at $5,985,051.90. This trade represents a 19.97% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 33,511 shares of company stock worth $9,714,580 in the last three months. 0.30% of the stock is currently owned by insiders.
Analysts Set New Price Targets
A number of research analysts have recently weighed in on CME shares. UBS Group increased their price objective on CME Group from $270.00 to $310.00 and gave the company a “neutral” rating in a report on Thursday, October 22nd. Wall Street Zen upgraded shares of CME Group from a “sell” rating to a “hold” rating in a research report on Saturday, October 31st. Bank of America upped their price objective on shares of CME Group from $226.00 to $230.00 and gave the company an “underperform” rating in a research note on Thursday, July 23rd. JPMorgan Chase & Co. upgraded CME Group from an “underweight” rating to an “overweight” rating and set a $367.00 price objective on the stock in a research note on Thursday, October 22nd. Finally, Deutsche Bank downgraded CME Group from a “buy” rating to a “hold” rating and dropped their price target for the stock from $286.00 to $270.00 in a research note on Wednesday, August 19th. Ten analysts have rated the stock with a Buy rating, six have issued a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, CME Group currently has a consensus rating of “Hold” and an average target price of $314.44.
Get Our Latest Stock Report on CME
CME Group Company Profile
CME Group operates a global marketplace for derivatives and other financial products. Through its exchanges—CME, CBOT, NYMEX and COMEX—it offers futures and options contracts tied to interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The company also provides clearing and settlement services, market data and related products. Its electronic trading platform, CME Globex, supports access to its markets by participants around the world, alongside its open-outcry and privately negotiated trading services.
Featured Articles
- Five stocks we like better than CME Group
- Drilling for Yield in the Gulf: Chevron Drops Anchor in Deepwater
- TJX Stock Flashes a Strong Bullish Signal as Its $3 Billion Buyback Plan Takes Shape
- Viking’s Low-Water Miss Looks Like a Buy-the-Dip Opportunity
- Why Amazon Wants the Chips and Blackstone Wants the Buildings
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.
